-
2561por Lafranceschina, Stefano, Brunetti, Oronzo, Delvecchio, Antonella, Conticchio, Maria, Ammendola, Michele, Currò, Giuseppe, Piardi, Tullio, de’Angelis, Nicola, Silvestris, Nicola, Memeo, Riccardo“…Background: Ablative techniques provide in patients with locally advanced pancreatic cancer (LAPC) symptomatic relief, survival benefit and potential downsizing. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2562
-
2563por Nishimura, Takashi, Mitsunaga, Makoto, Sawada, Ryoichi, Saruta, Masayuki, Kobayashi, Hisataka, Matsumoto, Noriko, Kanke, Toru, Yanai, Hiroyuki, Nakamura, KojiEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2564“…OBJECTIVES: Although there is evidence that aspirin might be able to prevent pancreatic cancer, the findings have been inconsistent. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2565“…Pancreatic cancer is one of the most malignant tumors worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2566por Ohkuma, Ryotaro, Yada, Erica, Ishikawa, Shumpei, Komura, Daisuke, Ishizaki, Hidenobu, Tamada, Koji, Kubota, Yutaro, Hamada, Kazuyuki, Ishida, Hiroo, Hirasawa, Yuya, Ariizumi, Hirotsugu, Satoh, Etsuko, Shida, Midori, Watanabe, Makoto, Onoue, Rie, Ando, Kiyohiro, Tsurutani, Junji, Yoshimura, Kiyoshi, Yokobori, Takehiko, Sasada, Tetsuro, Aoki, Takeshi, Murakami, Masahiko, Norose, Tomoko, Ohike, Nobuyuki, Takimoto, Masafumi, Izumizaki, Masahiko, Kobayashi, Shinichi, Tsunoda, Takuya, Wada, Satoshi“…Pancreatic cancer has an extremely poor prognosis, and identification of novel predictors of therapeutic efficacy and prognosis is urgently needed. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2567por Ishii, Noriko, Nishikawa, Hiroki, Iwata, Yoshinori, Enomoto, Hirayuki, Tanaka, Hironori, Katakami, Nobuyuki, Nishimura, Takashi, Iijima, Hiroko, Nishiguchi, Shuhei“…Aims: To construct a predictive model for overall survival (OS) in unresectable pancreatic cancer (PaC) undergoing systemic chemotherapy and to confirm its accuracy in an independent cohort. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2568por Zhang, Yiyin, Lei, Yubin, Xu, Jin, Hua, Jie, Zhang, Bo, Liu, Jiang, Liang, Chen, Meng, Qingcai, Yu, Xianjun, Shi, SiEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2569“…Activated pancreatic stellate cells (PSCs) are the main effector cells in the process of fibrosis, a major pathological feature in pancreatic diseases that including chronic pancreatitis and pancreatic cancer. During tumorigenesis, quiescent PSCs change into an active myofibroblast-like phenotype which could create a favorable tumor microenvironment and facilitate cancer progression by increasing proliferation, invasiveness and inducing treatment resistance of pancreatic cancer cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2570por Lowery, Maeve A.“…Pancreatic cancers occurring in carriers of a pathogenic germline alteration in BRCA1/2 (gBRCA1/2) are assumed to demonstrate homologous recombination repair deficiency (HRD), associated with sensitivity to platinum-based chemotherapy and synthetic lethality with PARP inhibitors (PARPi). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2571“…BACKGROUND: Pancreatic cancer has a poor prognosis; 40%–50% of patients have liver metastases at the time of initial diagnosis and only 15%–20% undergo surgical resection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2572por Bai, Yuru, Qiao, Lu, Xie, Ning, Li, Yan, Nie, Yongzhan, Pan, Yan, Shi, Yupeng, Wang, Jinhai, Liu, Na“…However, its role in pancreatic cancer has rarely been reported. In this study, we explored the expression and mechanisms of TOB1 in regulating the malignant phenotype of pancreatic cancer cells. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2573por Shakri, Ahmad Rushdi, Zhong, Timothy James, Ma, Wanchao, Coker, Courtney, Kim, Sean, Calluori, Stephanie, Scholze, Hanna, Szabolcs, Matthias, Caffrey, Thomas, Grandgenett, Paul M., Hollingsworth, Michael A., Tanji, Kurenai, Kluger, Michael D., Miller, George, Biswas, Anup Kumar, Acharyya, SwarnaliEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2574por Hasselluhn, Marie C., Klein, Lukas, Patzak, Melanie S., Buchholz, Sören M., Ströbel, Philipp, Ellenrieder, Volker, Maisonneuve, Patrick, Neesse, AlbrechtEnlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2575“…Further, we will present the current advances in the discovery of pancreatic cancer biomarkers with early diagnostic or prognostic potential, focusing on pancreas-specific (e.g., CUX2 or REG1A) or abnormal (e.g., ADAMTS1 or BNC1) cfDNA methylation signatures in high risk pre-neoplastic conditions and PDAC.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2576por Elechalawar, Chandra Kumar, Hossen, Md Nazir, Shankarappa, Priya, Peer, Cody J, Figg, William D, Robertson, J David, Bhattacharya, Resham, Mukherjee, Priyabrata“…INTRODUCTION AND OBJECTIVE: Pancreatic cancer (PC) is characterized by a robust desmoplastic environment, which limits the uptake of the standard first-line chemotherapeutic drug gemcitabine. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2577por Marková, Ivana, Koníčková, Renata, Vaňková, Kateřina, Leníček, Martin, Kolář, Michal, Strnad, Hynek, Hradilová, Miluše, Šáchová, Jana, Rasl, Jan, Klímová, Zuzana, Vomastek, Tomáš, Němečková, Ivana, Nachtigal, Petr, Vítek, Libor“…The aim of our study was to assess the possible anti‐angiogenic effects of A platensis in an experimental model of pancreatic cancer. The effects of an A platensis extract were investigated on human pancreatic cancer cells (PA‐TU‐8902) and immortalized endothelial‐like cells (Ea.hy926). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2578por Jiao, Feng, Han, Ting, Yuan, Cuncun, Liang, Yiyi, Cui, Jiujie, Zhuo, Meng, Wang, Liwei“…This study aims to analyze the effect of BRD4 on the cell growth and progression of pancreatic cancer and novel mechanisms involved. METHODS: Expression of BRD4 in pancreatic cancer and paired adjacent noncancerous tissues from 76 patients was analyzed by western blotting, immunohistochemistry, and real time PCR. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2579“…CONCLUSION: Our study suggested that ABO polymorphisms might serve as a risk factor of pancreatic cancers and cardiocerebrovascular diseases.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2580“…The prognosis of patients with pancreatic cancer continues to remain dismal, even though numerous trials have been conducted to establish more effective therapies in Japan and throughout the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto